Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01245621 · ClinicalTrials.gov registry record · NA
Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
NCT01245621 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 360 participants.
The verdict
NCT01245621, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
Study Summary
ENABLE III is a randomized clinical trial that evaluates a phone-based palliative care intervention designed to improve quality of life, mood, and symptom management for patients with an advanced stage cancer and their caregivers. The primary aims of this clinical trial are to determine whether a palliative care intervention (introduced immediately or 12 weeks after diagnosis) can improve survival, quality of life, mood, symptom intensity and end-of-life care.
Interventions
- BEHAVIORAL Later entry group
- BEHAVIORAL Early palliative care intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01245621
The ClinicalTrials.gov registry entry for NCT01245621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Later entry group is the first listed.
NCT01245621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01245621 about?
NCT01245621 is a clinical study titled "Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)". ENABLE III is a randomized clinical trial that evaluates a phone-based palliative care intervention designed to improve quality of life, mood, and symptom management for patients with an advanced stage cancer and their caregivers. The primary aims of this clinical trial are to determine whether a p...
What is the current status of trial NCT01245621?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2010-10. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01245621?
The interventions under investigation include: Later entry group (BEHAVIORAL), Early palliative care intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01245621?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.